S.Amdt. 3986Senate115th Congress (2017-2019)2nd degree
S.Amdt. 3986
Sponsored by
Sen. Marco Rubio (R-FL)
Submitted August 22, 2018
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
August 22, 2018
Text
Submitted
SA 3986. Mr. RUBIO submitted an amendment intended to be proposed to amendment SA 3695 proposed by Mr. Shelby to the bill H.R. 6157, making appropriations for the Department of Defense for the fiscal year ending September 30, 2019, and for other purposes; which was ordered to lie on the table; as follows: At the appropriate place in title II of division B, insert the following: Sec. ___. Not later than 90 days after the enactment of this Act, the Secretary of Health and Human Services shall submit a report to the Committee on Appropriations and the Committee on Finance of the Senate and the Committee on Appropriations and the Committee on Ways and Means of the House of Representatives, detailing the circumstances in which the Centers for Medicare & Medicaid Services may be providing Medicare or Medicaid payments to, or otherwise funding, entities that process genome or exome data in the People's Republic of China or the Russian Federation. The report shall outline the extent to which payments or other funding have been provided to such entities over the past 5 years, including amounts paid to each entity, the implications of such payments, including vulnerabilities, and specific recommendations on steps to ensure that payments are lawful and appropriate in the future. In developing the report, the Secretary shall also coordinate with other relevant agencies, as determined by the Secretary, to examine the potential effect of allowing beneficiaries' genome or exome data to be processed in the People's Republic of China or the Russian Federation on United States national security, United States intellectual property protections, HIPPA privacy protections, future biomedical development capabilities and competitiveness, and global competitiveness for United States laboratories. ______